Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-29 @ 10:40 PM
Study NCT ID:
NCT01610492
Status:
COMPLETED
Last Update Posted:
2017-10-13
First Post:
2012-05-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
116472
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None